| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NTRA over the last quarter tilts toward selling: insiders offloaded a net 278,788 shares worth roughly $65.7M. In the past 30 days, 0 insiders bought and 8 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 8 insiders sold in the same window, though all of them still hold shares. Classified under Life Sciences Tools & Services (Health Care sector), NTRA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 245.5K | $79.08M | -14,388 | |
| Pres | 183.8K | $59.19M | -2,008 | |
| Other | 170.1K | $54.78M | -2,221 | |
| Pres | 129.0K | $41.56M | -5,624 | |
| CEO | 101.8K | $32.79M | -8,846 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 | Sheena Jonathan46 | Director, Co-founder | Sell | 16,000 | $87.72 | $1,403,578.91 | -0.8% | +27.0% | +79.9% | |
| Feb 29, 2024 | Rabinowitz Daniel47 | Sec. And Chief Legal Officer | Sale+OE | 55,833 | $80.21 | $4,478,268.39 | -4.9% | +27.0% | +79.9% | |
| Feb 16, 2024 | Rosenman Herm46 | Director | Sale+OE | 93,901 | $69.37 | $6,514,371.49 | -37.1% | +55.0% | +147.7% | |
| Feb 7, 2024 | Sheena Jonathan46 | Director, Co-founder | Sell | 12,000 | $70.05 | $840,596.30 | -2.2% | +38.9% | +150.5% | |
| Feb 6, 2024 | Brophy Michael Burkes47 | Chief Financial Officer | Sale+OE | 34,029 | $70.03 | $2,383,129.14 | -32.5% | +38.4% | +152.1% | |
| Feb 1, 2024 | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 22,281 | $67.73 | $1,509,080.99 | -24.0% | +38.1% | +159.5% | |
| Jan 29, 2024 | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,426 | $65.09 | $223,002.11 | -1.7% | +41.6% | +153.1% | |
| Jan 29, 2024 | Rabinowitz Daniel47 | Sec. And Chief Legal Officer | Sell | 4,265 | $65.09 | $277,613.54 | -2.0% | +41.6% | +153.1% | |
| Jan 29, 2024 | Fesko John | President, Chief Bus. Officer | Sell | 2,358 | $65.09 | $153,484.81 | -2.1% | +41.6% | +153.1% | |
| Jan 29, 2024 | Sheena Jonathan46 | Director, Co-founder | Sell | 546 | $65.09 | $35,539.74 | -0.1% | +41.6% | +153.1% |